Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Hannover Re (HNRGn.DE)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (€)	Price Target (€)	Rating
2022-03-30	153.70	160.00	Neutral
2022-06-16	140.30	150.00	Neutral
2022-08-05	143.75	155.00	Neutral
2022-09-15	161.55	161.00	Neutral
2023-01-12	182.00	182.00	Sell
2023-02-08	181.75	177.00	Sell
2023-08-23	193.85	179.00	Sell
2023-11-10	202.10	185.00	Sell
2024-01-17	225.10	199.00	Sell
2024-03-19	255.70	214.00	Sell
2024-04-29	232.50	219.00	Sell
2024-06-03	232.80	234.00	Neutral
2024-08-14	236.50	238.00	Neutral
2024-10-18	257.70	267.00	Neutral
2025-04-15	275.60	280.00	Neutral
2025-05-15	276.00	275.00	Neutral
2025-06-24	266.80	280.00	Neutral

Disclosures

Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.